This annual conference is now in its 9th year and is well established as one of the leading events in the world, providing an international forum for dialogue and interaction between the leading world experts in Sickle Cell Disease (SCD) and Thalassaemia and health care professionals at the frontline of care.
The 2015 SCD conference will focus on:
- Health related quality of life for patients with SCD and thalassaemia
- Update on new therapies: new drugs, gene therapy and bone marrow transplantation
- Chronic complications including stroke, renal, bone and avascular necrosis
- Beta thalassaemia major and intermedia- non-transfusion dependent iron overload in thalassaemia
- Public health interventions to reduce the burden of SCD including improved awareness, disease prevention and early detection
- Best practice in managing the transition from paediatric to adulthood
- Global health issues in sickle cell and thalassaemia – how do we close the gap between the management of SCD in developing and developed countries?
- Update on iron chelation therapy: what options to use and when to initiate chelation